EPO Patents = 1

Trademarks = 3

Forward Citations = 9

Loading Chart...

10 inventors (with patents filed for the assignee):

Sofia De Achaval (6 out of 6 patents)

Imran Alibhai (4 out of 4 patents)

Beverly C Langevin (3 out of 4 patents)

4. Tian Zhou (3 out of 3 patents)

5. David John Tweardy (2 out of 6 patents)

6. Jeffrey Scott Larson (1 out of 20 patents)

7. Brad Henke (1 out of 1 patent)

8. William R Cantrell, Jr (11 patents)

9. William E Bauta (13 patents)

10. Sofia De Achaval Wied (0 patent)

6 patents: Sort by Forward Citations

1. 12053444 - Therapeutic compounds, formulations, and uses thereof (2024-08-06),

2. 12043640 - Prodrugs of STAT3 inhibitors (2024-07-23),

3. 11826315 - STAT3 inhibitors (2023-11-28),

4. 11547683 - Therapeutic compounds, formulations, and uses thereof (2023-01-10),

5. 11077077 - Therapeutic compounds, formulations, and uses thereof (2021-08-03),

6. 11026905 - STAT3 inhibitors (2021-06-08),

Tvardi Therapeutics, Inc. is a biotechnology company focused on developing targeted small molecule inhibitors for cancer treatment. Their innovative approach aims to deliver more effective and personalized therapies for cancer patients. With a strong team of scientists and researchers, Tvardi Therapeutics is dedicated to advancing the field of oncology and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

6 Patents

#711 in Houston, TX

#2,834 in Texas

#43,729 in US

Houston, TX, United States of America

Tvardi Therapeutics, Inc.